Suchergebnisse - (Subject:"CD3 Complex")

PubPharm (14.147)

61

The potential etiopathogenetic role and diagnostic utility of CD3+ CD56+ regulatory T lymphocytes in Myelodysplastic Syndromes

enthalten in: European journal of haematology | 2023

von Rubino, V. | Leone, S. | Carriero, F. | +3

62

Persistent decreased bone marrow CD3+ CD56+ T lymphocytes are inversely associated with mature granulocytes in myelodysplastic syndromes

enthalten in: European journal of haematology | 2023

von Serio, B. | Bertolini, A. | Gorrese, M. | +7

CommentOn: Eur J Haematol. 2022 Oct;109(4):398-405. - PMID 35775392

63

IMiDs Augment CD3-Bispecific Antibody-Induced CD8+ T-Cell Cytotoxicity and Expansion by Enhancing IL2 Production

enthalten in: Molecular cancer therapeutics | 2023

von Li, J. | Slaga, D. | Johnston, J. | +1

64

A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer

enthalten in: Journal of translational medicine | 2023

von Riillo, C. | Polerà, N. | Di Martino, M. | +15

65

Gene therapy with B-cell maturation antigen/CD3 bispecific antibody encoding plasmid DNA for treating multiple myeloma

enthalten in: British journal of haematology | 2023

von Peng, F. | Wang, Y. | Zhao, J. | +5

66

Construction of a novel TROP2/CD3 bispecific antibody with potent antitumor activity and reduced induction of Th1 cytokines

enthalten in: Protein expression and purification | 2023

von Wang, D. | Zhang, L. | Wang, B. | +4

67

IL-22-producing CD3 + CD8- T cells increase in immune clearance stage of chronic HBV infection and correlate with the response of Peg-interferon treatment

enthalten in: Clinical immunology (Orlando, Fla.) | 2023

von Wang, L. | Yang, X. | Wu, Y. | +1

68

Aberrant expression of T cell receptors in monocyte/macrophage RAW 264.7 cells : FCγRII/III compensates the need for CD3

enthalten in: Molecular immunology | 2023

von Antonopoulou, T. | Kanakousaki, E. | Dimitropoulos, C. | +2

69

Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors

enthalten in: Nature cancer | 2023

von Cattaruzza, F. | Nazeer, A. | To, M. | +14

CommentIn: Nat Cancer. 2023 Apr;4(4):439-441. - PMID 36997746

70

Expansion of mixed immune cells using CD3/CD161 co-stimulation for the treatment of cancer

enthalten in: Scientific reports | 2023

von Tsumura, R. | Haruta, M. | Kuwano, M. | +1